| abstract |
The disclosed subject matter relates to antibodies, compositions and methods for inhibiting and treating respiratory viral infections and transmission of respiratory viruses. In particular, the presently disclosed subject matter relates to inhibiting and treating viral infections in a subject using compositions and antibodies that entrap the virus within mucus, thereby inhibiting the passage of the virus through or through mucus secretions. |